Last updated: 11/07/2018 07:03:59
Korean practice patterns for screening PCA(prostate cancer)RESPECT
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Korean’s practice patterns for screening PCA(prostate cancer) according to PSA(prostate-specific antigen) level
Trial description: This is to investigate Korean urologist’s practice patterns for screening prostate cancer according to PSA level.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Number of subjects with prostate biopsy
Timeframe: 1year
Secondary outcomes:
Number of subjects with prostate cancer
Timeframe: 1year
Interventions:
Other: continuous screening
Enrollment:
1
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Mun Su Chung, Seung Hwan Lee , Dong Hoon Lee, Se Joong Kim, Choung Soo Kim, Kyu Sung Lee, Jae Il Jung, Sae Woong Kim, Yil Seob Lee, Byung Ha Chung. Practice Patterns for Screening and Managing Prostate Cancer according to PSA level (RESPECT Study). Yonsei Med J. 2012;53(6):1136-1141.
Medical condition
Neoplasms, Prostate, Benign Prostatic Hyperplasia
Product
Not applicable
Collaborators
Not applicable
Study date(s)
May 2010 to June 2011
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Male
Age
40+ years
Accepts healthy volunteers
No
- Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008
- Age less than 40 at PSA screening
- History of drug use which can affect level of PSA within 6months before PSA screening
Inclusion and exclusion criteria
Inclusion criteria:
- Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008
Exclusion criteria:
- Age less than 40 at PSA screening
- History of drug use which can affect level of PSA within 6months before PSA screening
- Subject who participate any other clinical trial
Trial location(s)
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2011-30-06
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website